跳至主要内容
临床试验/NCT04292041
NCT04292041Unknown不适用

Fasting Mimicking Diet in Prostate Cancer and Metabolic Syndrome, a Pilot Study

Galway Clinic1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2019年1月15日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
40
试验地点
1
主要终点
Change in Baseline Weight (in kilograms) at 6 months

研究概览

简要总结

This is a prospective observational cohort study of patients with prostate cancer who have a metabolic syndrome. The study aims to evaluate the role of intermittent fasting (fasting mimicking diet) in these patients. The primary end point is metabolic health and the secondary endpoint is quality of life.

详细描述

Cancer is a complex set of conditions which collectively comprise the second biggest cause of death in the western world. In addition, these diseases, along with their various treatments, are associated with significant illness, as well as a host of debilitating symptoms. Two very common problems are cancer fatigue, as well as metabolic changes which can cause much suffering in and of themselves. Patients with advanced cancers, as well as many patients undergoing surgery, radiation therapy as well as chemotherapy all complain of fatigue, to a greater or lesser extent. Many gain or lose weight, and develop associated metabolic changes in uninvolved body systems, which can cause a significant health burden on the patients, as well as the healthcare system as a whole.

Little is known about the mechanisms which underlie these symptoms. Various biologic processes have been implicated including inflammation and other changes in body metabolism. There is urgent need to better understand these processes, which cause so much suffering in cancer patients, so as to potentially develop more effective solutions.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
Male
接受健康志愿者

入选标准

  • Patients with biopsy-proven prostate cancer having features of a metabolic syndrome, receiving standard treatment options for their disease.

排除标准

  • Patients without a diagnosis of prostate cancer
  • Life expectancy less than 1 year
  • Children under the age of 18
  • Individuals who are allergic to nuts or soy
  • Individuals with a Body Mass Index (BMI) <18.5
  • Individuals who have been severely weakened by a disease or medical procedure
  • Individuals who are taking medications which may not be safely consumed with a calorie restricted diet unless authorised in writing by a licensed physician
  • Individuals with a history of significant cardiac disease, particularly uncompensated congestive heart failure NYHA grade 2 or more or LVEF <40% on any prior assessment
  • Individuals with a history of syncope (fainting) with calorie restriction or other medical co-morbidities
  • Individuals who have special dietary needs that are incompatible with the ProLon® meal plan
  • Individuals with liver or kidney disorders that may be affected by the very low glucose and protein content of the diet

结局指标

主要结局

Change in Baseline Weight (in kilograms) at 6 months

时间窗: Baseline and 3 months after Nutritional Cycle 3 (each cycle is 4 days per month), about 6 months

Metabolic health parameter

Change in Baseline Blood Pressure (in millimeters of Mercury) at 6 months

时间窗: Baseline and 3 months after Nutritional Cycle 3 (each cycle is 4 days per month), about 6 months

Metabolic health parameter

Change in Baseline Waist Circumference (in centimeters) at 6 months

时间窗: Baseline and 3 months after Nutritional Cycle 3 (each cycle is 4 days per month), about 6 months

Metabolic health parameter

Change in Baseline Triglycerides Level (in millimoles per litre) at 6 months

时间窗: Baseline and 3 months after Nutritional Cycle 3 (each cycle is 4 days per month), about 6 months

Clinical lab results

Change in Baseline Total, LDL, and HDL Cholesterol (in millimoles per litre) at 6 months

时间窗: Baseline and 3 months after Nutritional Cycle 3 (each cycle is 4 days per month), about 6 months

Clinical lab results

次要结局

  • Change in Baseline EQ5D5L Vertical Visual Analogue Scale Score at 6 months(Baseline and 3 months after Nutritional Cycle 3 (each cycle is 4 days per month), about 6 months)
  • Change in Baseline EQ5D5L Health Questionnaire Score at 6 months(Baseline and 3 months after Nutritional Cycle 3 (each cycle is 4 days per month), about 6 months)
  • Change in Baseline Chalder Fatigue Index Score at 6 months(Baseline and 3 months after Nutritional Cycle 3 (each cycle is 4 days per month), about 6 months)

研究者

发起方
Galway Clinic
申办方类型
Network
责任方
Principal Investigator
主要研究者

Professor Frank Sullivan

Medical Director, Department of Radiation Oncology

Galway Clinic

研究点 (1)

Loading locations...

相似试验